ZATTONI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 5.841
AS - Asia 695
EU - Europa 644
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 7.186
Nazione #
US - Stati Uniti d'America 5.830
CN - Cina 446
IT - Italia 294
VN - Vietnam 187
FI - Finlandia 89
DE - Germania 70
GB - Regno Unito 44
SE - Svezia 43
FR - Francia 31
IE - Irlanda 31
IN - India 20
JP - Giappone 17
NL - Olanda 10
CA - Canada 8
HK - Hong Kong 8
UA - Ucraina 7
RU - Federazione Russa 5
BG - Bulgaria 3
GR - Grecia 3
ID - Indonesia 3
MX - Messico 3
TR - Turchia 3
AR - Argentina 2
AT - Austria 2
CH - Svizzera 2
KR - Corea 2
OM - Oman 2
PL - Polonia 2
RO - Romania 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BE - Belgio 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
IR - Iran 1
LT - Lituania 1
MA - Marocco 1
MY - Malesia 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 7.186
Città #
Fairfield 1.199
Woodbridge 536
Ashburn 499
Chandler 474
Seattle 430
Houston 414
Cambridge 387
Wilmington 370
Ann Arbor 317
Dong Ket 185
San Diego 139
Princeton 119
Medford 117
Beijing 110
Des Moines 90
Padova 80
Guangzhou 78
Helsinki 67
Roxbury 57
Nanjing 46
Shanghai 32
Boardman 31
Dublin 28
Milan 22
New York 22
Nanchang 19
Jinan 17
Falls Church 16
Shenyang 14
Hebei 13
Tianjin 13
Jacksonville 12
Legnago 12
Ogden 11
Rome 11
London 10
Paris 10
Hefei 9
Jiaxing 9
Malo 9
Norwalk 9
Pune 9
Hong Kong 7
Prescot 7
Viterbo 7
Washington 7
Bonn 6
Cagliari 6
Detroit 6
Hangzhou 6
Hounslow 6
Pignone 6
Zhengzhou 6
Mira 5
Taiyuan 5
Trieste 5
Borås 4
Changsha 4
Chicago 4
Frankfurt am Main 4
Fuzhou 4
Haikou 4
Molinara 4
Rockville 4
Taizhou 4
Tokyo 4
Venice 4
Vicenza 4
Arezzo 3
Azzano Decimo 3
Conegliano 3
Dearborn 3
Delhi 3
Esslingen am Neckar 3
Kharkiv 3
Kunming 3
Leawood 3
Los Angeles 3
Montreal 3
New Bedfont 3
Noordwijk aan Zee 3
Noventa 3
Palermo 3
Phoenix 3
Abano Terme 2
Ames 2
Berlin 2
Bologna 2
Brendola 2
Buenos Aires 2
Camponogara 2
Dalian 2
Dianbu 2
Dresden 2
Falkenstein 2
Fontaniva 2
Hanoi 2
Heidelberg 2
Islington 2
Jakarta 2
Totale 6.265
Nome #
A 10-year history of secondary hypertension: A challenging case of renin-secreting juxtaglomerular cell tumor 171
The value of open conversion simulations during robot-assisted radical prostatectomy: Implications for robotic training curricula 150
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 149
Complex cystine kidney stones treated with combined robot-assisted laparoscopic pyelolithotomy and intraoperative renoscopy 141
The Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy 130
Spermatic Cord Sarcoma: Our Experience and Review of the Literature 119
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [18F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis 117
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 116
Ultrasound-guided transversus abdominis plane block (US-TAPb) for robot-assisted radical prostatectomy: a novel ‘4-point’ technique—results of a prospective, randomized study 112
Technical innovations to optimize continence recovery after robotic assisted radical prostatectomy 111
PET/MRI in prostate cancer: a systematic review and meta-analysis 109
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 106
Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer 105
Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy 103
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT 96
18F-fluoromethylcholine or 18F-fluoroethylcholine pet for prostate cancer imaging: Which is better? A literature revision 96
MP79-02 EVALUATION OF THE PROGNOSTIC IMPACT OF 18F-CHOLINE PET/CT IN PATIENTS WITH SKELETAL RECURRENCE PROSTATE CANCER 94
Effect of allogeneic intraoperative blood transfusion on survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution 88
Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy. 88
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma 87
Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. 85
Can 68GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer? 84
Why and How to Evaluate Chronic Prostatic Inflammation 83
PD11-01 COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY 83
THE WAR IS OPENED: PSMA VS. 64CuCL2 VS. CHOLINE PET/CT 82
Combined robotic-assisted retroperitoneoscopic partial nephrectomy and extraperitoneal prostatectomy. First case reported. 81
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES 79
Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer 78
Global minimally invasive pyeloplasty study in children: Results from the Pediatric Urology Expert Group of the European Association of Urology Young Academic Urologists working party 77
ULTRASOUND DETECTED NON-PALPABLE TESTICULAR LESIONS: WHAT DO YOU DO? 77
PD36-03 PERIOPERATIVE OUTCOMES OF OPEN RADICAL CYSTECTOMY IN OCTOGENARIANS: RESULTS FROM TWO HIGH-VOLUME CENTRES 76
Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial. 76
Correlation between pathologic features and perfusion CT of renal cancer: a feasibility study. 72
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis. 72
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil 72
Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy 71
Endourologic Diagnosis and Robotic Treatment of a Giant Fibroepithelial Polyp of the Ureter 70
Development of a Surgical Safety Training Program and Checklist for Conversion during Robotic Partial Nephrectomies 70
The Endourological Treatment of Renal Matrix Stones 69
Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse 69
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES 69
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) 69
Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy 69
Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results 68
68Ga-dotatoc vs.18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients 68
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 68
Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy 66
Prostate cancer: more effective use of underutilized postoperative radiation therapy 66
Income inequality and treatment of African American men with high-risk prostate cancer 65
Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg? 65
Posterior muscolofascial reconstruction incorporated into urethrovescical anastomosis during robot-assisted radical prostatectomy 65
MP55-05 PARTIAL NEPHRECTOMY IN THE TREATMENT OF RENAL TUMORS WITH CONCOMITANT VENOUS TUMOR THROMBOSIS (VTT) OF RENAL VEIN BRANCHES: RETROSPECTIVE, MULTI-CENTER ANALYSIS OF PERIOPERATIVE, FUNCTIONAL, AND ONCOLOGIC OUTCOMES 65
PD32-08 CHOLINE PET/CT SCAN FOR THE DETECTION OF NODAL RELAPSES OF PROSTATE CANCER AFTER BIOCHEMICAL RECURRENCE: RESULTS FROM A MULTICENTRIC STUDY 64
Perioperative outcomes and early survival in octogenarians who underwent radical cystectomy for bladder cancer 63
Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup 62
Risk stratification for benign prostatic hyperplasia 62
Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. 62
MP59-08 EXTERNAL VALIDATION OF RENAL TUMOUR CONTACT SURFACE AREA (CSA) IN PATIENTS WHO UNDERWENT PARTIAL NEPHRECTOMY 62
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 59
PD19-01 THE VALUE OF OPEN CONVERSION SIMULATIONS DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: IMPLICATIONS FOR ROBOTIC TRAINING CURRICULUMS 59
MP53-14 MULTIMODAL TREATMENT FOR HIGH-RISK PROSTATE CANCER WITH HIGH-DOSE INTENSITY-MODULATED RADIATION THERAPY, CONCURRENT INTENSIFIED-DOSE DOCETAXEL AND LONG-TERM ANDROGEN DEPRIVATION THERAPY AFTER RADICAL PROSTATECTOMY AND LYMPHADENECTOMY: RESULTS OF A PROSPECTIVE PHASE II TRIAL 58
Wunderlich's syndrome: three cases of acute spontaneous renal bleeding, conservatively treated. 57
Treating cervico-urethral obstructions with laser diode: initial clinical experience. 56
Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence 56
The impact of COVID-19 pandemic on pornography habits: a global analysis of Google Trends 54
Erratum: Why and how to evaluate chronic prostatic inflammation (European Urology (2013) 12:SUPPL. (110-5)) 53
The future of choline pet in the era of PMSA 52
PET/CT and urinary cancers: the message from urologists 52
PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES 52
MP57-13 LAPAROSCOPIC VERSUS PERCUTANEOUS CRYOABLATION FOR T1 RENAL MASSES: AN ITALIAN MULTICENTRIC STUDY 51
Is "extreme" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure? 51
Radiotherapy and concomitant docetaxel in high risk prostatic cancer:guone (north east uro oncology group) experience. 49
Re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive68Ga Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926–37 49
Should radical prostatectomy be encouraged at any age? A critical non-systematic review 49
PD43-04 COMPARING THE 8-YEAR ONCOLOGIC OUTCOMES OF OPEN AND ROBOT-ASSISTED RADICAL PROSTATECTOMY FOR HIGH RISK PROSTATE CANCER 49
MP69-05 ONCOLOGIC OUTCOMES AND BIOCHEMICAL PREDICTORS FOLLOWING SALVAGE LYMPH NODE DISSECTION FOR PROSTATE CANCER 48
MP53-07 NEED FOR A SURGICAL TEMPLATE IN SALVAGE LYMPHADENECTOMY FOR NODAL RECURRENCE OF PROSTATE CANCER: IS PELVIC INVOLVEMENT PREDICTIVE OF RETROPERITONEAL POSITIVITY? 46
RETROGRADE INTRA RENAL SURGERY (RIRS) FOR RENAL STONES 46
COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY 45
Minimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy 45
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 42
RETROGRADE INTRA RENAL SURGERY FOR RENAL STONES 42
CLINICAL EVOLUTION OF THE RENAL COLIC. AN OBSERVATIONAL STUDY 41
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 40
Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: A systematic review and meta-analysis 39
Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis 38
VE05 - How is a neobladder born? Ves.Pa.: ‘From lab to fab’ 37
Metabolic syndrome and stone disease 37
Re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926-37 35
Comparison between conventional imaging (CI) and wholebody 18F-choline (FCH) positron emission tomography/ computed tomography (PET/CT) in patients (pts) with prostate cancer (PCa) 33
The Future of Choline PET in the Era of Prostate Specific Membrane Antigen 33
Metabolic syndrome and prostate cancer treatment 32
MP67-14 PREDICTIVE VALUE OF NEGATIVE 3T MULTIPARAMETRIC PROSTATE MRI ON 12 CORE BIOPSY RESULTS 31
THE EFFECT OF PRIOR TURP ON COMPLICATIONS AND LONG-TERM OUTCOMES AFTER RADICAL PROSTATECTOMY: A 25-YEAR SINGLE INSTITUTION EXPERIENCE 29
Focal Therapy for Prostate Cancer: Complications and Their Treatment 28
Other than restaging phase: serial FCH-PET/CT scans can predict the reponse to chemotherapy (CT) in castrate-resistant prostate cancer (CRPCa)? 27
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer 27
Is there any benefit in adding postoperative adjuvant concurrent radiotherapy and chemotherapy for penile cancer with regional lymph node metastasis? 26
Endourological management of uretero-ileal anastomosis stricture after cystectomy and Vescica Ileale Padovana (V.I.P.) orthotopic neobladder reconstruction 26
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 25
Totale 6.796
Categoria #
all - tutte 32.959
article - articoli 31.505
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.464


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019520 0 0 0 0 0 0 0 0 0 106 228 186
2019/20201.791 167 40 64 176 282 137 180 205 214 163 104 59
2020/20211.151 54 74 81 137 33 57 57 93 128 114 104 219
2021/20221.556 45 183 162 87 66 158 127 132 68 76 119 333
2022/20231.091 238 82 20 112 157 137 26 66 120 10 87 36
2023/2024787 43 106 98 64 58 85 80 64 58 131 0 0
Totale 7.398